FDA committee to discuss low-dose paroxetine mesylate, Serada

FDA's Advisory Committee for Reproductive Health Drugs will meet on March 4 to discuss an NDA from Noven Pharmaceuticals Inc. for low-dose paroxetine mesylate and an NDA from Depomed Inc. (NASDAQ:DEPO...